ArticleGlobal health action2013
Implementation of misoprostol for postabortion care in Kenya and Uganda: a qualitative evaluation.
Article in Global health action, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.
- Barriers or gaps in implementation of misoprostol use for post-abortion care and post-partum hemorrhage prevention in developing countries: a systematic review.Reproductive health · 2017Pooled it
- Comparison of the effectiveness and safety of treatment of incomplete second trimester abortion with misoprostol provided by midwives and physicians: a randomised, controlled, equivalence trial in Uganda.The Lancet. Global health · 2022Trial
- Stigma related to contraceptive use and abortion in Kenya: scale development and validation.Reproductive health · 2019Trial
- Trial
- Quality of post-abortion care services in the greater Accra region: connecting the perspectives of service providers and experiences of clients.BMC pregnancy and childbirth · 2025Article
- Article
- Article
- Voluntary Contraceptive Uptake Among Postabortion Care Clients Treated With Misoprostol in Rwanda.Global health, science and practice · 2019Article
- Article
- Article
- Eliminating the high abortion related complications and deaths in Cameroon: the restrictive legal atmosphere on abortions is no acceptable excuse.BMC women's health · 2018Article
- Ethics challenges and guidance related to research involving adolescent post-abortion care: a scoping review.Reproductive health · 2018Article
- Policy, law and post-abortion care services in Kenya.PloS one · 2018Article
- Unsafe abortion in Kenya: a cross-sectional study of abortion complication severity and associated factors.BMC pregnancy and childbirth · 2015Article
- Barriers and facilitators in the provision of post-abortion care at district level in central Uganda - a qualitative study focusing on task sharing between physicians and midwives.BMC health services research · 2014Article
Corrections and comments
- Commented on by
- Commented on by
Authors and funding
5 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveEvaluate implementation of misoprostol for postabortion care (MPAC) in two African countries.
designQualitative, program evaluation.
settingTwenty-five public and private health facilities in Rift Valley Province, Kenya, and Kampala Province, Uganda. SAMPLE: Forty-five MPAC providers, health facility managers, Ministry of Health officials, and non-governmental (NGO) staff involved in program implementation. METHODS AND
main outcome measuresIn both countries, the Ministry of Health, local health centers and hospitals, and NGO staff developed evidence-based service delivery protocols to introduce MPAC in selected facilities; implementation extended from January 2009 to October 2010. Semi-structured, in-depth interviews evaluated the implementation process, identified supportive and inhibitive policies for implementation, elicited lessons learned during the process, and assessed provider satisfaction and providers' impressions of client satisfaction with MPAC. Project reports were also reviewed.
resultsIn both countries, MPAC was easy to use, and freed up provider time and health facility resources traditionally necessary for provision of PAC with uterine aspiration. On-going support of providers following training ensured high quality of care. Providers perceived that many women preferred MPAC, as they avoided instrumentation of the uterus, hospital admission, cost, and stigma associated with abortion. Appropriate registration of misoprostol for use in the pilot, and maintaining supplies of misoprostol, were significant challenges to service provision. Support from the Ministry of Health was necessary for successful implementation; lack of country-based standards and guidelines for MPAC created challenges.
conclusionsMPAC is simple, cost-effective and can be readily implemented in settings with high rates of abortion-related mortality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.